Mankind Pharma's Stock Sees Positive Growth, Outperforms Sector and Sensex
On October 29, 2024, Mankind Pharma's stock price on the BSE closed at Rs. 2495.75, showing a 3.21% increase. The stock has outperformed the sector by 4.44% and has shown a trend reversal after 11 days of fall. Despite trading below some moving averages, the company has consistently delivered positive results and remains a key player in the Indian pharmaceutical industry.
Mankind Pharma, a leading pharmaceutical company in India, has seen a positive growth in its stock price on October 29, 2024. The stock has gained 3.21%, closing at Rs. 2495.75 on the Bombay Stock Exchange (BSE). This performance has been deemed as 'Hold' by MarketsMOJO, a leading stock market analysis platform.
The stock has outperformed the sector by 4.44% and has shown a trend reversal after 11 consecutive days of fall. The day's high for the stock was Rs. 2508.65, a 3.32% increase from the previous day's closing. However, the stock is currently trading below its 5-day, 20-day, and 50-day moving averages, but is higher than its 100-day and 200-day moving averages.
In comparison to the overall market performance, Mankind Pharma has outperformed the Sensex by 3.61% in the past 1 day and has shown a better performance in the past 1 month as well, with a -3.43% change compared to Sensex's -6.62%.
Mankind Pharma, a largecap company in the pharmaceutical and drugs industry, has been consistently delivering positive results and has shown resilience in the face of market fluctuations. With its strong presence in the Indian market and a diverse portfolio of products, the company continues to be a key player in the industry. Investors can keep a close watch on the stock's performance in the coming days.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
